Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

213 Odcinki

  1. Fluvoxamine for Treating COVID-19

    Opublikowany: 7.01.2022
  2. Prescribing Antidepressants During Breastfeeding

    Opublikowany: 2.01.2022
  3. Treatment Strategies for Acute and Chronic Insomnia

    Opublikowany: 28.12.2021
  4. Drug Use in Breastfeeding and Adverse Effects

    Opublikowany: 23.12.2021
  5. Marine Omega-3 Fatty Acid Supplementation for BPD

    Opublikowany: 18.12.2021
  6. Breastfeeding and Estimating Infant Drug Exposure

    Opublikowany: 13.12.2021
  7. A Method for Tapering Antipsychotics

    Opublikowany: 8.12.2021
  8. Management of Psychiatric Comorbidities With Alcohol Use Disorder

    Opublikowany: 3.12.2021
  9. Tips for Treating Perimenopausal Depression

    Opublikowany: 28.11.2021
  10. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

    Opublikowany: 23.11.2021
  11. Subclinical Hypothyroidism in Depressed Adolescents

    Opublikowany: 18.11.2021
  12. Principles for Managing Alcohol Use Disorder

    Opublikowany: 13.11.2021
  13. ECT for Depressed Patients With Borderline Personality Disorder

    Opublikowany: 8.11.2021
  14. Assessing and Treating Alcohol Withdrawal

    Opublikowany: 3.11.2021
  15. Lab Tests in Psychopharmacology

    Opublikowany: 29.10.2021
  16. Technology-Facilitated Adherence Enhancement and Family Involvement

    Opublikowany: 24.10.2021
  17. Drug-Induced Hyperthermic Syndromes in Psychiatry

    Opublikowany: 19.10.2021
  18. How to Improve Adherence: Targeting Reasons for Nonadherence

    Opublikowany: 14.10.2021
  19. Esketamine: Postmarketing Safety Concerns

    Opublikowany: 9.10.2021
  20. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Opublikowany: 4.10.2021

10 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site